Gene · 23013
Papers1,651
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,651
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immune checkpoint inhibitor-related molecular markers predict prognosis in extrahepatic cholangiocarcinoma. | Cancer Med | 2023 | 37814942 | PubTator, text mining | PubMed |
| Somatic mutations reveal hyperactive Notch signaling and racial disparities in prurigo nodularis. | medRxiv | 2023 | 37808834 | PubTator, text mining | PubMed |
| Gene partners of the EWSR1 fusion may represent molecularly distinct entities. | Transl Oncol | 2023 | 37797367 | PubTator, text mining | PubMed |
| Modulation of Notch Signaling by Small-Molecular Compounds and Its Potential in Anticancer Studies. | Cancers (Basel) | 2023 | 37760535 | PubTator, text mining | PubMed |
| Establishment and validation of an immune infiltration predictive model for ovarian cancer. | BMC Med Genomics | 2023 | 37759229 | PubTator, text mining | PubMed |
| Development of a novel tumor microenvironment-related radiogenomics model for prognosis prediction in hepatocellular carcinoma. | Quant Imaging Med Surg | 2023 | 37711809 | PubTator, text mining | PubMed |
| Genomic profiling of post-transplant lymphoproliferative disorders using cell-free DNA. | J Hematol Oncol | 2023 | 37705050 | PubTator, text mining | PubMed |
| Genomic characterization of thymic epithelial tumors in a real-world dataset. | ESMO Open | 2023 | 37703595 | PubTator, text mining | PubMed |
| Abnormal genetic and epigenetic patterns of m6A regulators associated with tumor microenvironment in colorectal cancer. | Transl Cancer Res | 2023 | 37701104 | PubTator, text mining | PubMed |
| Human papillomavirus vaccine impact on invasive cervical cancer in Japan: Preliminary results from cancer statistics and the MINT study. | Cancer Sci | 2023 | 37688310 | PubTator, text mining | PubMed |
| An immunogenic cell death-related classification predicts prognosis and response to immunotherapy in kidney renal clear cell carcinoma. | Front Oncol | 2023 | 37681027 | PubTator, text mining | PubMed |
| Pseudotemporal ordering of spatial lymphoid tissue microenvironment profiles trails Unclassified DLBCL at the periphery of the follicle. | Front Immunol | 2023 | 37680642 | PubTator, text mining | PubMed |
| The many faces of nodal and splenic marginal zone lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop. | Virchows Arch | 2023 | 37656249 | PubTator, text mining | PubMed |
| PINK1 and Parkin regulate IP3R-mediated ER calcium release. | Nat Commun | 2023 | 37626046 | PubTator, text mining | PubMed |
| Pan-cancer analysis identifies SPEN mutation as a predictive biomarker with the efficacy of immunotherapy. | BMC Cancer | 2023 | 37620924 | PubTator, text mining | PubMed |
| Evaluation of the anticancer activity of RIN-1, a Notch signaling modulator, in head and neck squamous cell carcinoma. | Sci Rep | 2023 | 37607974 | PubTator, text mining | PubMed |
| Repression of rRNA gene transcription by endothelial SPEN deficiency normalizes tumor vasculature via nucleolar stress. | J Clin Invest | 2023 | 37607001 | PubTator, text mining | PubMed |
| Association of PIK3CA mutation with outcomes in HER2-positive breast cancer treated with anti-HER2 therapy: A meta-analysis and bioinformatic analysis of TCGA‑BRCA data. | Transl Oncol | 2023 | 37597296 | PubTator, text mining | PubMed |
| Serum tRF-27-FDXXE6XRK45 as a Promising Biomarker for the Clinical Diagnosis in Gastric Cancer. | Int J Med Sci | 2023 | 37575270 | PubTator, text mining | PubMed |
| Short-term exposure to ethanol induces transcriptional changes in nontumorigenic breast cells. | FEBS Open Bio | 2023 | 37572351 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23013/papers?page=9